About Me
Dr. Janet Dancey is an international leader in novel trials of targeted cancer therapies with associated biomarkers, and for rare cancers patients. As Director of the Canadian Cancer Trials Group (CCTG), Canada's largest cancer trial network, she advanced its research strategy and expanded its portfolio of trials evaluating targeted agents, immunotherapy and application of genomics. She has championed expanding the roles of patients in setting research priorities and activities. Dr. Dancey has expertise in drug and biomarker development, and trials methodology. A prolific author with an excellent citation record, she is a sought-after speaker, both nationally and internationally.